Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,502.00    -48.00 (-3.10%)
Bid:
1,494.00
Ask:
1,498.00
Spread: 4.00 (0.268%)
Market Cap: £783.50m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Share buyback programme

16 Jun 2022 07:00

RNS Number : 0468P
M. P. Evans Group PLC
16 June 2022
 

M.P. EVANS GROUP PLC

("Group" or "M.P. Evans")

Share buyback programme

The board of directors of MP Evans ("Board") is pleased to announce that it intends to commence a share buyback programme of £2 million ("Programme") from the date of this announcement. All shares acquired under the Programme will be cancelled.

The Board continues to believe that the current share price undervalues the Group's assets, the performance of the business to date and its future prospects. The Group's robust balance sheet provides the opportunity to take advantage of prevailing market conditions to repurchase shares at advantageous levels that will be earnings enhancing.

The Group is undertaking this Programme as part of a disciplined approach to capital allocation, which includes continuing investment across its estates, the ongoing pursuit of strategic acquisition opportunities and payment of dividends at an increased level. The Board sees a case for buybacks being economically attractive since the Group's shares are currently trading below the share price implied by the independent valuation of its assets.

The Programme will operate under the authority granted to the Group by shareholders at the Group's most recent Annual General Meeting, held on 10 June 2022, and within the regulatory limit on the quantity of shares the Group may purchase on any single day. The Programme will be undertaken using a phased approach and have an initial duration of up to 3 calendar months.

The board will keep the programme under review and will make a decision in due course on whether to extend it.

In order to implement the Programme, MP Evans has entered into an agreement with Peel Hunt LLP for them independently to carry out on-market purchases of its 10p shares. The Programme will be conducted in compliance with the Market Abuse Regulation (EU) No. 596/2014 and the delegated regulations made pursuant to it.

16 June 2022

 

Enquiries:

M.P. Evans Group PLC

Telephone: 01892 516333

Peter Hadsley-Chaplin - chairman

Matthew Coulson - chief executive

Peel Hunt LLP (Nomad and joint broker)

Telephone: 020 7418 8900

Dan Webster, Andrew Clark, Lalit Bose

finnCap (Joint broker)

Telephone: 020 7220 0500

Tim Redfern, Harriet Ward

Hudson Sandler (Financial PR)

Telephone: 020 7796 4133

Charlie Jack, Elfie Kent, Francis Kerrigan

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFAMFTMTTBBPT
Date   Source Headline
29th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSNotice of interim results & investor presentation
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
14th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20237:00 amRNSTransaction in Own Shares
3rd Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
1st Aug 20237:00 amRNSAppointment of new director
31st Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSTransaction in Own Shares
21st Jul 20237:00 amRNSTransaction in Own Shares
20th Jul 20237:00 amRNSTransaction in Own Shares
20th Jul 20237:00 amRNSCrop and production update
19th Jul 20237:00 amRNSTransaction in Own Shares
18th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSTransaction in Own Shares
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:05 amRNSTransaction in Own Shares
12th Jul 20237:05 amRNSCorrective announcement and Total voting rights
7th Jul 202311:27 amRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSDirector/PDMR Shareholding
3rd Jul 202312:08 pmRNSTotal Voting Rights
3rd Jul 20239:12 amRNSBlock listing Interim Review
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20237:00 amRNSTransaction in Own Shares
14th Jun 20237:00 amRNSShare buyback programme
9th Jun 20233:00 pmRNSRESULTS OF GENERAL MEETING
9th Jun 20237:00 amRNSTrading Statement
8th Jun 20237:00 amRNSTransaction in Own Shares
7th Jun 20237:00 amRNSAGM arrangements
7th Jun 20237:00 amRNSTransaction in Own Shares
2nd Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 20233:06 pmRNSTotal Voting Rights
31st May 20237:00 amRNSBoard and senior management changes
31st May 20237:00 amRNSTransaction in Own Shares
25th May 20234:47 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.